Ticker
TCRXCompany Name
TSCAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQ| Date | Operating Margin | Operating Income | Revenues |
|---|---|---|---|
| 6/30/2025 | -2072.07% | $ -144.24M | $ 6.96M |
| 3/31/2025 | -3159.87% | $ -139.7M | $ 4.42M |
| 12/31/2024 | -4787.68% | $ -134.82M | $ 2.82M |
| 9/30/2024 | -1276.07% | $ -119.47M | $ 9.36M |
| 6/30/2024 | -914.69% | $ -111.59M | $ 12.2M |
| 3/31/2024 | -689.22% | $ -102.09M | $ 14.81M |
| 12/31/2023 | -444% | $ -93.46M | $ 21.05M |
| 9/30/2023 | -535.94% | $ -90.75M | $ 16.93M |
| 6/30/2023 | -503.26% | $ -82.58M | $ 16.41M |
| 3/31/2023 | -422.8% | $ -73.22M | $ 17.32M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Op. Inc. / Revenues
(=) Operating % Operating % for TSCAN THERAPEUTICS INC is calculated as follows: Op. Inc. [ $ -26.23M ] / Revenues [ $ 1.08M ]
(=) Operating % [ -2417.79% ] Minimum
Dec 31, 2024
Maximum
Mar 31, 2023
Average
Median
| filtered constituents | 3.26K |
|---|---|
| min | -71.54% |
| max | 83.41% |
| average | 9.03% |
| median | 8.77% |
| std | 23.72% |